methylprednisolone hemisuccinate has been researched along with Guillain-Barre Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apjok, E; Magyarosy, E; Marosi, A | 1 |
| Jin, JP; Link, H; Pashenkov, M; Press, R | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Guillain-Barre Syndrome
| Article | Year |
|---|---|
[Guillain-Barré syndrome in patients treated for Hodgkin disease].
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Male; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Paraneoplastic Syndromes, Nervous System; Treatment Outcome | 2003 |
Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adult; Chemokine CCL19; Chemokine CCL2; Chemokine CXCL10; Chemokines; Chemokines, CC; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2003 |